FAH and hepatocellular carcinoma: The study further asserts that patients with HT-1 also face long-term risks for developing hepatocellular carcinoma due to a deficiency in FAH and, thereby, the accumulation of toxic metabolites, causing progressive liver and kidney damage and neurological crises [7].